• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Soluble Epoxide Hydrolase Regulation of Lipid Mediators Limits Pain.可溶性环氧化物水解酶对脂类介质的调节限制疼痛。
Neurotherapeutics. 2020 Jul;17(3):900-916. doi: 10.1007/s13311-020-00916-4.
2
Soluble epoxide hydrolase as a therapeutic target for pain, inflammatory and neurodegenerative diseases.可溶性环氧化物水解酶作为治疗疼痛、炎症和神经退行性疾病的靶点。
Pharmacol Ther. 2017 Dec;180:62-76. doi: 10.1016/j.pharmthera.2017.06.006. Epub 2017 Jun 19.
3
Epoxy Fatty Acids Are Promising Targets for Treatment of Pain, Cardiovascular Disease and Other Indications Characterized by Mitochondrial Dysfunction, Endoplasmic Stress and Inflammation.环氧脂肪酸是治疗疼痛、心血管疾病和其他以线粒体功能障碍、内质网应激和炎症为特征的疾病的有前途的靶点。
Adv Exp Med Biol. 2020;1274:71-99. doi: 10.1007/978-3-030-50621-6_5.
4
Modulation of mitochondrial dysfunction and endoplasmic reticulum stress are key mechanisms for the wide-ranging actions of epoxy fatty acids and soluble epoxide hydrolase inhibitors.调节线粒体功能障碍和内质网应激是环氧脂肪酸和可溶性环氧水解酶抑制剂广泛作用的关键机制。
Prostaglandins Other Lipid Mediat. 2017 Nov;133:68-78. doi: 10.1016/j.prostaglandins.2017.08.003. Epub 2017 Aug 25.
5
A Soluble Epoxide Hydrolase Inhibitor, 1-TrifluoromethoxyPhenyl-3-(1-Propionylpiperidin-4-yl) Urea, Ameliorates Experimental Autoimmune Encephalomyelitis.一种可溶型环氧化物水解酶抑制剂,1-三氟甲氧基苯基-3-(1-丙酰基哌啶-4-基)脲,可改善实验性自身免疫性脑脊髓炎。
Int J Mol Sci. 2021 Apr 28;22(9):4650. doi: 10.3390/ijms22094650.
6
Eicosanoid profiles in an arthritis model: Effects of a soluble epoxide hydrolase inhibitor.关节炎模型中的类二十烷酸代谢产物谱:一种可溶性环氧化物水解酶抑制剂的作用。
Biochim Biophys Acta Mol Cell Biol Lipids. 2024 Mar;1869(2):159432. doi: 10.1016/j.bbalip.2023.159432. Epub 2023 Nov 19.
7
Soluble epoxide hydrolase inhibition alleviates neuropathy in Akita (Ins2 Akita) mice.可溶性环氧化物水解酶抑制可减轻阿基塔(Ins2 Akita)小鼠的神经病变。
Behav Brain Res. 2017 May 30;326:69-76. doi: 10.1016/j.bbr.2017.02.048. Epub 2017 Mar 1.
8
The role of long chain fatty acids and their epoxide metabolites in nociceptive signaling.长链脂肪酸及其环氧代谢产物在伤害性信号传导中的作用。
Prostaglandins Other Lipid Mediat. 2014 Oct;113-115:2-12. doi: 10.1016/j.prostaglandins.2014.09.001. Epub 2014 Sep 18.
9
Regulatory lipid vicinal diols counteract the biological activity of epoxy fatty acids and can act as biomarkers and mechanisms for disease progression.调节性脂类顺式二醇可拮抗环氧脂肪酸的生物学活性,可作为疾病进展的生物标志物和机制。
Pharmacol Ther. 2023 Aug;248:108454. doi: 10.1016/j.pharmthera.2023.108454. Epub 2023 Jun 1.
10
Targeting the soluble epoxide hydrolase pathway as a novel therapeutic approach for the treatment of pain.靶向可溶性环氧化物水解酶途径作为治疗疼痛的一种新的治疗方法。
Curr Opin Pharmacol. 2024 Oct;78:102477. doi: 10.1016/j.coph.2024.102477. Epub 2024 Aug 27.

引用本文的文献

1
4-Phenyl-thiazole-based dual inhibitors of fatty acid amide hydrolase and soluble epoxide hydrolase do not alleviate orofacial inflammatory pain in female rats.基于4-苯基噻唑的脂肪酸酰胺水解酶和可溶性环氧化物水解酶双重抑制剂不能减轻雌性大鼠的口面部炎性疼痛。
BBA Adv. 2024 Aug 8;6:100119. doi: 10.1016/j.bbadva.2024.100119. eCollection 2024.
2
Epigenetic combined with transcriptomic analysis of the m6A methylome after spared nerve injury-induced neuropathic pain in mice.小鼠 spared 神经损伤诱导的神经性疼痛后 m6A 甲基化组的表观遗传学与转录组学联合分析
Neural Regen Res. 2023 Nov;18(11):2545-2552. doi: 10.4103/1673-5374.371374.
3
Soluble epoxide hydrolase inhibition alleviates chemotherapy induced neuropathic pain.可溶性环氧化物水解酶抑制可减轻化疗诱导的神经性疼痛。
Front Pain Res (Lausanne). 2023 Jan 9;3:1100524. doi: 10.3389/fpain.2022.1100524. eCollection 2022.
4
Synthesis, In Vitro Profiling, and In Vivo Evaluation of Benzohomoadamantane-Based Ureas for Visceral Pain: A New Indication for Soluble Epoxide Hydrolase Inhibitors.苯并同金刚烷基脲类化合物的合成、体外分析及内脏痛的体内评价:可溶性环氧化物水解酶抑制剂的一个新适应证。
J Med Chem. 2022 Oct 27;65(20):13660-13680. doi: 10.1021/acs.jmedchem.2c00515. Epub 2022 Oct 12.
5
Molecular and cellular mechanisms of itch and pain in atopic dermatitis and implications for novel therapeutics.特应性皮炎中瘙痒和疼痛的分子与细胞机制及其对新型疗法的意义
Clin Transl Immunology. 2022 May 9;11(5):e1390. doi: 10.1002/cti2.1390. eCollection 2022.
6
Structure-guided discovery of potent and oral soluble epoxide hydrolase inhibitors for the treatment of neuropathic pain.基于结构导向发现强效口服可溶性环氧化物水解酶抑制剂用于治疗神经性疼痛
Acta Pharm Sin B. 2022 Mar;12(3):1377-1389. doi: 10.1016/j.apsb.2021.09.018. Epub 2021 Sep 22.
7
Proteasome Inhibitors and Their Pharmacokinetics, Pharmacodynamics, and Metabolism.蛋白酶体抑制剂及其药代动力学、药效学和代谢。
Int J Mol Sci. 2021 Oct 27;22(21):11595. doi: 10.3390/ijms222111595.
8
Pain Treatment in the Companion Canine Model to Validate Rodent Results and Incentivize the Transition to Human Clinical Trials.伴侣犬模型中的疼痛治疗,以验证啮齿动物实验结果并推动向人类临床试验的过渡。
Front Pharmacol. 2021 Aug 5;12:705743. doi: 10.3389/fphar.2021.705743. eCollection 2021.
9
Discovery of memantyl urea derivatives as potent soluble epoxide hydrolase inhibitors against lipopolysaccharide-induced sepsis.发现美金刚脲衍生物作为有效的可溶性环氧化物水解酶抑制剂可对抗脂多糖诱导的败血症。
Eur J Med Chem. 2021 Nov 5;223:113678. doi: 10.1016/j.ejmech.2021.113678. Epub 2021 Jun 29.
10
A Soluble Epoxide Hydrolase Inhibitor, 1-TrifluoromethoxyPhenyl-3-(1-Propionylpiperidin-4-yl) Urea, Ameliorates Experimental Autoimmune Encephalomyelitis.一种可溶型环氧化物水解酶抑制剂,1-三氟甲氧基苯基-3-(1-丙酰基哌啶-4-基)脲,可改善实验性自身免疫性脑脊髓炎。
Int J Mol Sci. 2021 Apr 28;22(9):4650. doi: 10.3390/ijms22094650.

可溶性环氧化物水解酶对脂类介质的调节限制疼痛。

Soluble Epoxide Hydrolase Regulation of Lipid Mediators Limits Pain.

机构信息

Department of Entomology and Nematology and University of California Davis Comprehensive Cancer Center, University of California Davis, One Shields Avenue, Davis, California, 95616, USA.

Department of Neurobiology, Physiology, and Behavior, University of California, Davis, California, USA.

出版信息

Neurotherapeutics. 2020 Jul;17(3):900-916. doi: 10.1007/s13311-020-00916-4.

DOI:10.1007/s13311-020-00916-4
PMID:32875445
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7609775/
Abstract

The role of lipids in pain signaling is well established and built on decades of knowledge about the pain and inflammation produced by prostaglandin and leukotriene metabolites of cyclooxygenase and lipoxygenase metabolism, respectively. The analgesic properties of other lipid metabolites are more recently coming to light. Lipid metabolites have been observed to act directly at ion channels and G protein-coupled receptors on nociceptive neurons as well as act indirectly at cellular membranes. Cytochrome P450 metabolism of specifically long-chain fatty acids forms epoxide metabolites, the epoxy-fatty acids (EpFA). The biological role of these metabolites has been found to mediate analgesia in several types of pain pathology. EpFA act through a variety of direct and indirect mechanisms to limit pain and inflammation including nuclear receptor agonism, limiting endoplasmic reticulum stress and blocking mitochondrial dysfunction. Small molecule inhibitors of the soluble epoxide hydrolase can stabilize the EpFA in vivo, and this approach has demonstrated relief in preclinical modeled pain pathology. Moreover, the ability to block neuroinflammation extends the potential benefit of targeting soluble epoxide hydrolase to maintain EpFA for neuroprotection in neurodegenerative disease.

摘要

脂质在疼痛信号转导中的作用已经得到充分证实,这是基于数十年关于前列腺素和白三烯代谢物分别引起疼痛和炎症的知识。其他脂质代谢物的镇痛特性最近才被发现。脂质代谢物被观察到直接作用于伤害感受神经元上的离子通道和 G 蛋白偶联受体,以及间接作用于细胞膜上。细胞色素 P450 对特定长链脂肪酸的代谢形成环氧化物代谢物,即环氧脂肪酸 (EpFA)。这些代谢物的生物学作用已被发现可在多种类型的疼痛病理中介导镇痛作用。EpFA 通过多种直接和间接机制发挥作用,限制疼痛和炎症,包括核受体激动剂、限制内质网应激和阻断线粒体功能障碍。可溶性环氧化物水解酶的小分子抑制剂可以稳定体内的 EpFA,这种方法已在临床前模拟疼痛病理模型中证明了缓解作用。此外,阻断神经炎症的能力扩展了靶向可溶性环氧化物水解酶以维持 EpFA 用于神经退行性疾病神经保护的潜在益处。